Pathways impacted by genomic alterations in pulmonary carcinoid tumors

Medicine & Life Sciences

• Carcinoid Tumor 100%
• Lung 47%
• Neoplasm Genes 28%
• Biological Phenomena 17%
• Whole Exome Sequencing 10%
• Whole Genome Sequencing 10%
• Amyloid beta-Protein Precursor 10%
• Neuroendocrine Tumors 9%
• Mutation 9%
• Small Cell Lung Carcinoma 9%
• MAP Kinase Signaling System 9%
• NF-kappa B 9%
• Neoplasms 8%
• Single Nucleotide Polymorphism 7%
• Genes 7%
• Research Design 6%
• Cell Cycle 6%
• Cell Death 6%
• Data Analysis 6%
• Apoptosis 5%
• Gene Expression 5%
• Messenger RNA 5%
• Therapeutics 2%